Mycophenolic acid

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 04.03.2021

Dieser Artikel auf Deutsch

Synonym(s)

CAS number: 24280-93-1

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

HistoryThis section has been translated automatically.

Mycophenolic acid was isolated and crystallized by Bartolomeo Gosio in 1893. He observed that this mycotoxin inhibited the growth of anthrax pathogens. The correct structure of the substance was clarified by Birkinshaw in 1952.

DefinitionThis section has been translated automatically.

Mycophenolic acid (molecular formula:C17H20O6) is a substance belonging to the mycotoxins produced by the moulds Penicillium brevicompactum, Penicillium carneum and Penicillium roqueforti.

General informationThis section has been translated automatically.

Mycophenolic acid (MPA) is a highly effective, selective and reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH). Mycophenolic acid inhibits the de novo pathway of synthesis of guanine-containing nucleotides (guanosine). Since the de novo synthesis of purines is essential for the proliferation of T and B lymphocytes, while other cell types can use the salvage pathway, mycophenolic acid has a stronger cytostatic effect on lymphocytes than on other cells. There is a high interindividual variability in the pharmacokinetics of mycophenolic acid. An ester of mycophenolic acid, the mycophenolate mofetil, is used to suppress organ rejection after kidney and heart transplants. After administration, the ester is converted back into free mycophenolic acid in the body.

Note(s)This section has been translated automatically.

Other mycotoxins include:

Authors

Last updated on: 04.03.2021